K143466 is an FDA 510(k) clearance for the Hemogrip Patch. Classified as Hemostatic Wound Dressing Without Thrombin Or Other Biologics (product code QSY).
Submitted by Remedium Technologies, Inc. (College Park, US). The FDA issued a Cleared decision on June 8, 2015 after a review of 186 days - an extended review cycle.
This device falls under the General & Plastic Surgery FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.
View all Remedium Technologies, Inc. devices